Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Detailed Action
Claims 33-49 submitted on 05/19/2026 are pending for examination.
In reply to the non-final action of 02/09/2026, the applicants’ argument is acknowledged. Rejections and/or objections not reiterated from previous office actions 02/09/2026 are hereby withdrawn.
Claim Objection
Objection of claims 34-35 and 42-43 for the recitation of “per mol rhGAA”. Claim 33 was amended to insert “of” but claims 34-35 and 42-43 were not amended. Correction Required.
Objection of claim 36 for missing a conjunction in line 3, between “glycan” and “at least”.
Correction Required.
Objection of claims 36-37 for the recitation of the acronym “CIMPR”.
Correction Required.
Rejection
Claim Rejections 35 U.S.C 112(b) rejection
The following is a quotation of 35 U.S.C. 112(b):
(b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention.
Claim 34-35 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention.
Claim 34 is rejected because for lack of antecedence for reciting “the average content of N- glycans carrying M6P”. Claim 34 depends on claim 33. Claim 33 does not recite” average content of N- glycans carrying M6P”. Therefore Claim 34 lack of antecedence for reciting the average content of N- glycans carrying M6P.
Claim 35 is rejected because for lack of antecedence for reciting “the average content of N- glycans carrying M6P”. Claim 34 depends on claim 33. Claim 33 does not recite” average content of N- glycans carrying M6P”. Therefore Claim 34 lack of antecedence for reciting the average content of N- glycans carrying M6P.
Conclusion
Claims 34-35 are rejected. Claims 34-37 and 42-43 are objected. Claims 33, 38-41 and 44-49 are allowed,.
Any inquiry concerning this communication or earlier communications from the
examiner should be directed to Mohammad Meah whose telephone number is 571-272-
1261. The examiner can normally be reached on 8:30-5PM.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s
supervisor, Robert Mondesi can be reached on 4089187584. The fax phone number
for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of an application may be obtained from the
Patent Application Information Retrieval (PAIR) system. Status information for
published applications may be obtained from either Private PAIR or Public PAIR.
Status information for unpublished applications is available through Private PAIR only.
For more information about the PAIR system, see http://pair-direct.uspto.gov. Should
you have questions on access to the Private PAIR system.
/MOHAMMAD Y MEAH/Examiner, Art Unit 1652
Prosecution Insights